---
schema_version: "secwatch.filing_event.v1"
accession: "0000929638-24-000084"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:38:22.533295+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical appoints David Green as CFO effective Jan 10, 2024

## Summary
- David Green, 61, appointed CFO; previously CFO at BlackSwan Vascular and LamaMed Solutions.
- Annual base salary of $375,000; eligible for annual bonus up to 40% of base salary.
- Grant of 450,000 RSUs vesting 25% on first anniversary, remainder monthly over 36 months.
- Caryl Baron, former Interim CFO, transitions to VP of Finance effective Jan 10, 2024.
- Green brings 25+ years healthcare finance experience; also served as Interim CFO of Prolacta Bioscience.

## SEC filing metadata
- accession: 0000929638-24-000084
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/a8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000929638-24-000084
- JSON: https://secwatch.observer/filing/0000929638-24-000084.json
- Plain text: https://secwatch.observer/filing/0000929638-24-000084.txt

## Key facts
- Executive change
  Caryl Baron changed role as Vice President of Finance at SeaStar Medical Holding Corp.
  - Action: transitioned into the role of
  - Role: Vice President of Finance
  source text: Also effective on January 10, 2024, Caryl Baron, who served as the Interim Chief Financial Officer of the Company since October 2022, will transition into the role of Vice President of Finance of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm
- Executive change
  David Green was appointed as Chief Financial Officer at SeaStar Medical Holding Corp.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On January 10, 2024, the Board of Directors (the “Board”) of SeaStar Medical Holding Corporation (the “Company”) appointed David Green, age 61, as the Company’s Chief Financial Officer, effective as of January 10, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000092963824000084/0000929638-24-000084-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.